Otsuka Holdings Co Ltd (OTSKY)
OTHER OTC:OTSKY
Want to see OTSKY full AI Analyst Report?
OTSKY Stock Chart & Stats
$29.69
-$0.33(-1.23%)
At close: 4:00 PM EST
$29.69
-$0.33(-1.23%)
Day’s Range― - ―
52-Week Range$22.13 - $36.80
Previous CloseN/A
Volume11.00K
Average Volume (3M)4.89K
Market Cap
$33.58B
Enterprise Value$5.83T
Total Cash (Recent Filing)$540.63B
Total Debt (Recent Filing)$195.47B
Price to Earnings (P/E)14.3
Beta0.05
Next Earnings
Jul 30, 2026EPS Estimate
0.48Next Dividend Ex-DateN/A
Dividend Yield1.48%
Share Statistics
EPS (TTM)360.32
Shares Outstanding1,085,977,800
10 Day Avg. Volume2,307
30 Day Avg. Volume4,892
Financial Highlights & Ratios
PEG Ratio0.93
Price to Book (P/B)1.55
Price to Sales (P/S)1.82
P/FCF Ratio14.23
Enterprise Value/Market Cap173.71
Enterprise Value/Revenue2.29
Enterprise Value/Gross Profit3.20
Enterprise Value/Ebitda10.05
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)1.88
Revenue Forecast (FY)$16.26B
Bulls Say, Bears Say
Bulls Say
Diversified Business ModelOtsuka’s dual-segment model (prescription pharmaceuticals plus nutraceuticals/functional foods) provides durable revenue diversification. This reduces reliance on any single product or market, smoothing cash flows and supporting investment capacity across R&D and consumer brands over the medium term.
High And Improving ProfitabilityVery strong TTM margins indicate structural pricing power and cost efficiency across businesses. High gross and operating margins support sustained cash generation, funding for R&D and commercialization, and provide a durable buffer versus cyclical downturns or competitive pressure over the next several quarters.
Conservative Balance SheetExtremely low leverage gives the company financial flexibility to invest in pipeline development, M&A, or absorb shocks without refinancing stress. Improved ROE shows better capital efficiency post-recovery, supporting long-term return sustainability if earnings remain on the current trajectory.
Bears Say
Inconsistent Cash ConversionOperating cash conversion is only moderate and FCF growth has slightly declined, indicating working-capital or timing volatility. That inconsistency can constrain funding for R&D, launches, or dividends without drawing on reserves, making near-term investment planning less predictable.
Revenue And Margin VolatilityHistorical swings (notably the 2023 margin dip then rebound) and only modest TTM revenue growth suggest execution and operating-leverage risk. Sustaining improved margins depends on steady sales and cost control; any slowdown could quickly reverse recent profitability gains.
Pharma Reliance On Pipeline And ApprovalsA large portion of revenue hinges on successful drug development, label expansions, and country-level reimbursement. Regulatory setbacks, trial failures, or pricing pressure represent structural downside risks to revenue predictability and can materially affect cash flow and growth over the medium term.
Otsuka Holdings Co News
OTSKY FAQ
What was Otsuka Holdings Co Ltd’s price range in the past 12 months?
Otsuka Holdings Co Ltd lowest stock price was $22.13 and its highest was $36.80 in the past 12 months.
What is Otsuka Holdings Co Ltd’s market cap?
Otsuka Holdings Co Ltd’s market cap is $33.58B.
When is Otsuka Holdings Co Ltd’s upcoming earnings report date?
Otsuka Holdings Co Ltd’s upcoming earnings report date is Jul 30, 2026 which is in 45 days.
How were Otsuka Holdings Co Ltd’s earnings last quarter?
Otsuka Holdings Co Ltd released its earnings results on Apr 28, 2026. The company reported $0.583 earnings per share for the quarter, beating the consensus estimate of $0.431 by $0.152.
Is Otsuka Holdings Co Ltd overvalued?
According to Wall Street analysts Otsuka Holdings Co Ltd’s price is currently Overvalued.
Does Otsuka Holdings Co Ltd pay dividends?
Otsuka Holdings Co Ltd pays a Semiannually dividend of $0.44 which represents an annual dividend yield of 1.48%. See more information on Otsuka Holdings Co Ltd dividends here
What is Otsuka Holdings Co Ltd’s EPS estimate?
Otsuka Holdings Co Ltd’s EPS estimate is 0.48.
How many shares outstanding does Otsuka Holdings Co Ltd have?
Otsuka Holdings Co Ltd has 1,085,977,800 shares outstanding.
What happened to Otsuka Holdings Co Ltd’s price movement after its last earnings report?
Otsuka Holdings Co Ltd reported an EPS of $0.583 in its last earnings report, beating expectations of $0.431. Following the earnings report the stock price went up 4.703%.
Which hedge fund is a major shareholder of Otsuka Holdings Co Ltd?
Currently, no hedge funds are holding shares in OTSKY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Otsuka Holdings Co Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-9.37%
12-Months-Change
Fundamentals
Return on Equity
12.85%
Trailing 12-Months
Asset Growth
7.13%
Trailing 12-Months
Company Description
Otsuka Holdings Co Ltd
Otsuka Holdings Co., Ltd., founded in Tokyo, Japan, in 1921, is a global enterprise with diverse operations spanning pharmaceuticals, nutraceuticals, consumer products, and a multitude of other ventures. In the pharmaceutical realm, the company concentrates on developing treatments and diagnostic tools for various medical fields, including oncology, cardiovascular, renal, digestive, and ophthalmic conditions, as well as intravenous solutions and medical devices. Its robust consumer health and nutraceutical division features popular brands like EQUELLE for women's health, BODYMAINTÉ conditioning foods and drinks, the widely recognized rehydration beverage POCARI SWEAT, nutritional sustenance from Calorie Mate, the oral rehydration solution OS-1, and the household antiseptic Oronine H Ointment. Furthermore, Otsuka's extensive portfolio stretches into diverse areas such as beverages (soft drinks, wines), various chemicals, specialized manufacturing (e.g., plastics, paper, ceramics, functional films), clinical testing and medical equipment, cosmetics, logistics, analytical tools, software solutions for mental healthcare, and hospitality services through its hotel operations.
Technical Analysis
Ownership Overview
―
Insiders
<0.01% Mutual Funds
0.28% Other Institutional Investors
99.71% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---